221 related articles for article (PubMed ID: 9034333)
1. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis.
Desaintes C; Demeret C; Goyat S; Yaniv M; Thierry F
EMBO J; 1997 Feb; 16(3):504-14. PubMed ID: 9034333
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
4. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
5. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.
Huang SM; Schönthal AH; Stallcup MR
Oncogene; 2001 Apr; 20(17):2134-43. PubMed ID: 11360197
[TBL] [Abstract][Full Text] [Related]
8. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Goodwin EC; DiMaio D
Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus type 18 (HPV18) replication protein E1 is a transcriptional activator when interacting with HPV18 E2.
Demeret C; Goyat S; Yaniv M; Thierry F
Virology; 1998 Mar; 242(2):378-86. PubMed ID: 9514974
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome.
Kurg R; Uusen P; Võsa L; Ustav M
Virology; 2010 Dec; 408(2):159-66. PubMed ID: 20940072
[TBL] [Abstract][Full Text] [Related]
13. Physical and functional interactions of human papillomavirus E2 protein with nuclear receptor coactivators.
Wu MH; Huang CJ; Liu ST; Liu PY; Ho CL; Huang SM
Biochem Biophys Res Commun; 2007 May; 356(3):523-8. PubMed ID: 17376404
[TBL] [Abstract][Full Text] [Related]
14. HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells.
Lee D; Kwon JH; Kim EH; Kim ES; Choi KY
Cancer Lett; 2010 Jun; 292(1):125-32. PubMed ID: 20036050
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.
Seewaldt VL; Mrózek K; Dietze EC; Parker M; Caldwell LE
Cancer Res; 2001 Jan; 61(2):616-24. PubMed ID: 11212259
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.
Kurg R; Tekkel H; Abroi A; Ustav M
J Virol; 2006 Nov; 80(22):11218-25. PubMed ID: 16943289
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
18. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.
Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL
Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435
[TBL] [Abstract][Full Text] [Related]
19. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
20. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
